Sf9, Baculovirus cells.
Interferon alpha/beta receptor 2, IFNAR2, IFN-alpha binding protein, Interferon alpha binding protein, Type I interferon receptor 2, interferon alpha/beta receptor 2 isoform a, IFN-R-2, IFNABR, IFNARB, IFN-alpha-REC, IFN-R, IMD45.
Greater than 90.0% as determined by SDS-PAGE.
IFNAR2 Human Recombinant produced in Baculovirus is a single glycosylated polypeptide chain containing 456 amino acids (27-243 a.a.) and having a molecular mass of 51.7kDa. IFNAR2 is fused to an 239 amino acid hIgG-His tag at C-terminus and purified by proprietary chromatographic techniques.
Interferon alpha/beta receptor 2, IFNAR2, IFN-alpha binding protein, Interferon alpha binding protein, Type I interferon receptor 2, interferon alpha/beta receptor 2 isoform a, IFN-R-2, IFNABR, IFNARB, IFN-alpha-REC, IFN-R, IMD45.
Sf9, Baculovirus cells.
ISYDSPDYTD ESCTFKISLR NFRSILSWEL KNHSIVPTHY TLLYTIMSKP EDLKVVKNCA NTTRSFCDLT DEWRSTHEAY VTVLEGFSGN TTLFSCSHNF WLAIDMSFEP PEFEIVGFTN HINVMVKFPS IVEEELQFDL SLVIEEQSEG IVKKHKPEIK GNMSGNFTYI IDKLIPNTNY CVSVYLEHSD EQAVIKSPLK CTLLPPGQES ESAESAKLEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPGK HHHHHH.
IFNAR2 is a glycoprotein that belongs to the class II cytokine receptor family . It forms a heterodimeric receptor complex with IFNAR1, another subunit of the type I interferon receptor . This receptor complex binds to type I interferons, which include interferons-α, -β, -ε, -κ, -ω, and -ζ . Upon binding to these interferons, IFNAR2 activates several signaling pathways, including the JAK-STAT pathway, MAPK, PI3K, and Akt signaling pathways .
The activation of IFNAR2 leads to the transcription of over 2000 different genes, resulting in a wide range of biological effects . These effects include antiviral responses, modulation of cell differentiation, proliferation, apoptosis, and autophagy . The diverse effects of type I interferons are dependent on the cellular and environmental context .
Recombinant human IFNAR2 is produced using recombinant DNA technology, which involves inserting the gene encoding IFNAR2 into a suitable expression system, such as Chinese Hamster Ovary (CHO) cells . This allows for the large-scale production of IFNAR2 for research and therapeutic purposes. Recombinant IFNAR2 is used in various studies to understand its role in immune responses and to develop potential therapeutic applications .
The type I interferons, including those that bind to IFNAR2, have been extensively studied for their antiviral, antitumor, and immunomodulatory properties . Recombinant human IFNAR2 is used in research to explore these properties and to develop new treatments for viral infections, cancers, and autoimmune diseases .